WuXi Biologics (Cayman) Inc. (BKK:WUXI06)
Thailand flag Thailand · Delayed Price · Currency is THB
3.300
-0.100 (-2.94%)
At close: Nov 18, 2025

WuXi Biologics Ratios and Metrics

Millions THB. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
544,496318,596550,0781,121,1411,664,6971,625,805
Upgrade
Market Cap Growth
75.24%-42.08%-50.94%-32.65%2.39%233.20%
Upgrade
Enterprise Value
529,361313,963540,3211,098,0481,618,7251,619,264
Upgrade
PE Ratio
28.6220.1933.3750.6193.99209.36
Upgrade
PS Ratio
5.993.636.6614.6530.9563.00
Upgrade
PB Ratio
2.451.492.586.189.7416.92
Upgrade
P/TBV Ratio
2.791.702.966.7910.5617.69
Upgrade
P/FCF Ratio
68.2752.62182.37---
Upgrade
P/OCF Ratio
20.9912.9924.3140.3792.82187.95
Upgrade
EV/Sales Ratio
5.793.586.5414.3530.1062.75
Upgrade
EV/EBITDA Ratio
16.6911.4222.6143.2285.50198.82
Upgrade
EV/EBIT Ratio
21.1514.5628.3450.3697.69234.41
Upgrade
EV/FCF Ratio
66.3751.85179.13---
Upgrade
Debt / Equity Ratio
0.100.110.100.120.130.16
Upgrade
Debt / EBITDA Ratio
0.730.820.890.861.181.85
Upgrade
Debt / FCF Ratio
2.903.847.33---
Upgrade
Asset Turnover
0.340.330.320.330.280.24
Upgrade
Inventory Turnover
6.366.715.044.313.944.15
Upgrade
Quick Ratio
2.401.982.351.561.852.49
Upgrade
Current Ratio
2.882.732.781.982.373.16
Upgrade
Return on Equity (ROE)
10.51%8.82%8.90%13.20%13.09%10.02%
Upgrade
Return on Assets (ROA)
5.89%5.05%4.63%5.81%5.43%4.03%
Upgrade
Return on Capital (ROIC)
6.64%5.79%5.51%7.00%6.47%4.78%
Upgrade
Return on Capital Employed (ROCE)
10.60%9.50%8.00%10.80%8.90%6.10%
Upgrade
Earnings Yield
3.49%4.95%3.00%1.98%1.06%0.48%
Upgrade
FCF Yield
1.46%1.90%0.55%-0.15%-0.97%-1.17%
Upgrade
Buyback Yield / Dilution
2.55%2.80%0.62%1.04%-5.05%-5.30%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.